According to the Qichacha APP, Tianjin Jiuyin Electronic Technology Co., Ltd. was recently established, with Li Kang as the legal representative and a registered capital of 500000 yuan. Its business scope includes: sales of satellite mobile communication terminals; Sales of navigation terminals; Sales of wearable smart devices; Sales of intelligent unmanned aerial vehicles, etc. Qichacha's equity penetration shows that the company is wholly owned by Andon Health.

In the field of medical applications, the "low altitude+medical rescue" unmanned aerial vehicle comprehensive solution has achieved normalized low altitude medical transportation services in multiple provinces and cities across the country. With the help of unmanned aerial vehicle technology, it innovates three key medical logistics scenarios: blood transportation, medical material distribution, and rapid response to emergency supplies. Will Jiu'an be involved in this direction in the future? Worth paying attention to.

Has launched multiple wearable products, with asset management becoming one of its main businesses
Andon Health is a famous medical stock during the epidemic. With the sales of COVID-19 Antigen household self-test OTC kits in the United States, the company achieved a revenue of more than 20 billion in three months, and its stock price soared 16 times in half a year. Therefore, Andon Health is also known as the "monster stock".

According to the 2023 annual report of Andon Health, the company achieved a total operating revenue of approximately 3.231 billion yuan, a year-on-year decrease of 87.72%. The net profit attributable to shareholders of the listed company was approximately 1.252 billion yuan, a year-on-year decrease of 92.19%, and the non deductible net profit attributable to shareholders of the listed company was 1.004 billion yuan, a year-on-year decrease of 93.86%.

Although the revenue and profit have significantly decreased compared to 2022, in 2019 before the epidemic, Andon Health's revenue and non deductible profit were 706 million yuan and -240 million yuan respectively. Now, not only has its profit turned around and exceeded 1 billion yuan, but its revenue has also increased by 4.5 times.

According to its 2023 annual report, "asset management" and "joint investment and direct investment with professional investors" have become one of the main businesses of Andon Health.

According to the annual report, Andon Health has specially established a professional asset management team and hired professionals with rich experience in the field of asset management. Its wholly-owned subsidiary, Jiu'an Hong Kong Limited, serves as a specialized investment subsidiary and engages in asset management business with its own funds. In addition, the company has expanded its investment business scope, including investment activities and investment management using its own funds.

At the same time, Andon Health hopes to strategically invest in cutting-edge technology fields such as hard technology, medical health, artificial intelligence, biomanufacturing, new energy, and new materials in order to obtain long-term investment returns.

From the perspective of business scope, the new company established by Andon Health also conforms to the above investment logic. According to Qichacha Information, Tianjin Jiuyin Electronic Technology Co., Ltd. was established on September 6, 2024, with Li Kang as the legal representative and a registered capital of 500000 RMB. Its industry includes computer, communication, and other electronic equipment manufacturing.

The detailed business scope includes: technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion; Electronic product sales; Retail of computer software, hardware, and auxiliary equipment; Home appliance installation services; Conference and exhibition services; Retail of musical instruments; Sales of household audiovisual equipment; Sales of household appliances; Sales of non electric household appliances; Sales of household appliance spare parts; Retail of daily household appliances; Sales of electric food processing equipment; Sales of daily miscellaneous goods; Sales of daily necessities; Sales of audio equipment; Scale sales; Retail of photographic equipment and telescopes; Retail of hardware products; Sales of smart home consumer devices; Sales of daily chemical products; Sales of wooden toys; Toy sales; Sales of maternal and child products; Sales of metal tools; Sales of daily necessities; Retail of kitchenware, sanitary ware, and daily necessities; Retail of sports goods and equipment; Sales of wind and electric tools; Sales of communication equipment; Retail of stationery supplies; Sales of satellite mobile communication terminals; Sales of navigation terminals; Sales of network equipment; Sales of refrigeration and air conditioning equipment; Sales of wearable smart devices; Sales of intelligent instruments and meters; Sales of intelligent unmanned aerial vehicles; Sales of office equipment; Sales of office supplies; Sales of office equipment and consumables; Clothing and apparel retail; Luggage sales; Sales of leather products; Sales of Class II medical devices. (Except for projects that require approval according to law, conduct business activities independently based on the business license in accordance with the law).

Among them, the sales of satellite mobile communication terminals, wearable smart devices, and intelligent unmanned aerial vehicles are the most eye-catching and closely related to cutting-edge technology fields. From the previous business layout of Andon Health, it can be seen that as early as early May 2013, Andon Health announced its involvement in wearable devices and had close ties with mobile phone manufacturers.

On June 10, 2010, the company was listed on the Shenzhen SME Board in the same year, transformed to the mobile Internet and created an independent innovative brand "iHealth", launched a mobile Internet sphygmomanometer connected to Apple mobile phones, which was strongly supported by Apple in the United States and entered Apple's online official website and offline direct marketing channels.

Subsequently, personal health wearable devices covering areas such as blood pressure, blood glucose, blood oxygen, electrocardiogram, heart rate, weight, body fat, sleep, and exercise were successively launched. And obtained a strategic investment of 25 million US dollars from Xiaomi Technology, becoming a partner of Xiaomi's ecosystem. As for the drone field, Jiu'an had no relevant layout before.

Continuously entering the fields of new energy and AI
After the epidemic, Andon Health's unconventional cross-border layout has repeatedly attracted market attention.

Firstly, in the field of new energy vehicles, in 2022, Andon Health continuously purchased stocks of Xiaopeng Motors, Ideal Motors, and NIO, with a total investment of approximately 350 million yuan. According to the 2024 interim report, Andon Health has increased its investment in Tesla. Tianjin Jiupeng Automobile Sales and Service Co., Ltd. and Zaozhuang Jiupeng Automobile Sales and Service Co., Ltd. have also been established successively, mainly selling Xiaopeng automobiles.

However, in recent investor relations events, when faced with questions from investors, did they have plans to enter the field of new energy vehicles? Andon Health denied it, saying that the company has always focused on the development of its main business, promoting the implementation of two core strategies, namely, "popular products" and "accelerating the promotion of the new model of diabetes diagnosis and treatment care 'O+O' (Offline+Online) in China and the United States". Operating the Xiaopeng sales store is just a relatively independent business unit of the company, which is independently decided by the department. Currently, the investment scale is not large and has a small impact on the main business, so it is still in the trial stage.

In addition, Liu Yi, Chairman of Andon Health, stated during an investor relations event that the company's major asset allocation involves investments in the technology sector and collaborates with excellent investment managers. AI is one of our key areas of focus.
This reminds us of the incident this year when Andon Health's stock price skyrocketed due to the popularity of "Kimi".

On March 18, 2024, Moonshot AI announced that its products would increase the lossless context length from 200000 words to 2 million words. This innovation has attracted widespread attention in the capital market, leading to a surge in concept stocks related to Kimi.

According to the announcement from Andon Health, in August 2023, the wholly-owned subsidiary of the company, Jiu'an Hong Kong Limited (Jiu'an Hong Kong), signed an investment agreement with entities related to the dark side of the month, with an investment amount equivalent to approximately 10 million US dollars. In March 2024, the Tianjin Jiushang No.1 Management Consulting Partnership Enterprise (Limited Partnership), in which the company participated in the investment (with Jiu'an Hong Kong indirectly holding 98.68% of the investment shares of the partnership enterprise), signed an investment agreement with relevant parties on the dark side of the month, with an investment amount equivalent to approximately 20 million US dollars.

Based on this calculation, Andon Health's investment in the dark side of the moon reached 30 million US dollars, approximately 216 million RMB.

According to Andon Health's 24-hour semi annual report, in the investment field, the company has conducted in-depth research on over 300 top asset management and fund companies worldwide, and actively participated in more than 500 specialized conferences related to global first-line investment institutions, enhancing the company's visibility and awareness in the professional field. At present, the company has established investment cooperation relationships with more than 20 first-line asset management companies, continuously improving the comprehensive ability of the company's asset allocation in various categories.

At the same time, in order to fully utilize the abundant resources of universities, the company has cooperated with well-known universities such as Tianjin University, committed to finding and supporting promising entrepreneurial teams and projects. The company participated in the 5 billion RMB Tiankai Jiu'an Haihe Haitang Science and Technology Innovation Mother Fund. The fund aims to attract and screen high-quality venture capital institutions across the country through market-oriented mechanisms, and jointly create a diversified venture capital fund cluster covering different stages of development such as angel investment, technological innovation, and growth enterprises.

This means that in the future, we will see the presence of Andon Health in more fields; Focusing on two core strategies, CGM conducts pre clinical trials
However, as Andon Health responded, the company is still focused on its main business.

Regarding its main business, the core strategy of Andon Health currently includes two parts: one is the strategy of selling popular products. With the widespread use of iHealth kits, iHealth is well-known in the United States. The company will continue to leverage iHealth's popularity and user reputation in the United States, and promote more market competitive technologies and products to the US market, especially home medical electronic products and IVD products.

It is reported that since the establishment of its subsidiary iHealthLabs Inc. in Silicon Valley, USA in 2010, Andon Health has successfully launched the first generation of IoT blood pressure monitors under the iHealth brand and continued to expand its product line, launching a variety of IoT home medical and health products such as blood glucose meters, thermometers, oximeters, and iHealth test kits.

Second, the new model of "O+O" (Offline+Online) for diabetes diagnosis and treatment care. The company took the lead in implementing the strategy of "Internet plus medical treatment" with diabetes management as the entry point to help diabetes comprehensive care throughout the course of disease.

It is reported that the prototype of Andon Health's Continuous Glucose Monitor (CGMS) has been completed and is currently in the preclinical stage. This project is related to the company's core strategic business, and the company will focus its efforts and resources on accelerating the progress of this project.

Source: http://qixieke.com/Font/index/detailPage.html?id=3190-19